ResearcherActive in the last 2 years
Peter Sidaway
Matched on OpenAlex author ID A5013570864.
Their work
- Papers
- 10 (first author 10, last author 0)
- Trials
- 0
- Grants
- 0
- Collaborators
- 0
2016: 2 papers · 2017: 6 papers · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 10
- Daraxonrasib effective in metastatic pancreatic ductal adenocarcinoma. First author DOI 10.1038/s41571-026-01176-5↗
- Pancreatic cancer: Mass spectrometry indicates malignant potential. First author DOI 10.1038/nrclinonc.2017.199↗
- EGFR inhibition is effective against KRAS-wild-type disease First author DOI 10.1038/nrclinonc.2017.119↗
- Pancreatic cancer: TCGA data reveal a highly heterogeneous disease. First author DOI 10.1038/nrclinonc.2017.146↗
- Pancreatic cancer: Addition of capecitabine prolongs overall survival. First author DOI 10.1038/nrclinonc.2017.21↗
- Pancreatic cancer: Pancreatic cancer cells digest extracellular protein. First author DOI 10.1038/nrclinonc.2017.3↗
- New biomarkers improve standard screening First author DOI 10.1038/nrclinonc.2017.35↗
- Pancreatic cancer: ROCK inhibition sensitizes preclinical models. First author DOI 10.1038/nrclinonc.2017.67↗
- Pancreatic cancer: FAK regulates sensitivity to immunotherapy. First author DOI 10.1038/nrclinonc.2016.116↗
- Testicular cancer: Radiotherapy increases pancreatic cancer risk. First author DOI 10.1038/nrurol.2016.190↗
Closest collaborators
No collaborators recorded.
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.